Comments to FDA: Significant Scientific Agreement

Share page:
Docket Number:
99D-5424

CHPA submits these written comments in response to FDA’s notice in the Federal Register concerning “Guidance for Industry: Significant Scientific Agreement in the Review of Health Claims for Conventional Foods and Dietary Supplements.”

Related Posts

Weight Loss Products

OTC Sales Tax Exemptions